Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep:276:161-167.
doi: 10.1016/j.ejogrb.2022.07.010. Epub 2022 Jul 19.

Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study

E Mullins  1 , A Perry  2 , J Banerjee  3 , J Townson  4 , D Grozeva  4 , R Milton  4 , N Kirby  4 , R Playle  4 , T Bourne  5 , C Lees  6 ; PAN-COVID Investigators
Collaborators, Affiliations

Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study

E Mullins et al. Eur J Obstet Gynecol Reprod Biol. 2022 Sep.

Abstract

Objective: To assess perinatal outcomes for pregnancies affected by suspected or confirmed SARS-CoV-2 infection.

Methods: Prospective, web-based registry. Pregnant women were invited to participate if they had suspected or confirmed SARS-CoV-2 infection between 1st January 2020 and 31st March 2021 to assess the impact of infection on maternal and perinatal outcomes including miscarriage, stillbirth, fetal growth restriction, pre-term birth and transmission to the infant.

Results: Between April 2020 and March 2021, the study recruited 8239 participants who had suspected or confirmed SARs-CoV-2 infection episodes in pregnancy between January 2020 and March 2021. Maternal death affected 14/8197 (0.2%) participants, 176/8187 (2.2%) of participants required ventilatory support. Pre-eclampsia affected 389/8189 (4.8%) participants, eclampsia was reported in 40/ 8024 (0.5%) of all participants. Stillbirth affected 35/8187 (0.4 %) participants. In participants delivering within 2 weeks of delivery 21/2686 (0.8 %) were affected by stillbirth compared with 8/4596 (0.2 %) delivering ≥ 2 weeks after infection (95 % CI 0.3-1.0). SGA affected 744/7696 (9.3 %) of livebirths, FGR affected 360/8175 (4.4 %) of all pregnancies. Pre-term birth occurred in 922/8066 (11.5%), the majority of these were indicated pre-term births, 220/7987 (2.8%) participants experienced spontaneous pre-term births. Early neonatal deaths affected 11/8050 livebirths. Of all neonates, 80/7993 (1.0%) tested positive for SARS-CoV-2.

Conclusions: Infection was associated with indicated pre-term birth, most commonly for fetal compromise. The overall proportions of women affected by SGA and FGR were not higher than expected, however there was the proportion affected by stillbirth in participants delivering within 2 weeks of infection was significantly higher than those delivering ≥ 2 weeks after infection. We suggest that clinicians' threshold for delivery should be low if there are concerns with fetal movements or fetal heart rate monitoring in the time around infection. The proportion affected by pre-eclampsia amongst participants was not higher than would be expected, although we report a higher than expected proportion affected by eclampsia. There appears to be no effect on birthweight or congenital malformations in women affected by SARS-CoV-2 infection in pregnancy and neonatal infection is uncommon. This study reflects a population with a range of infection severity for SARS-COV-2 in pregnancy, generalisable to whole obstetric populations.

Keywords: COVID; Fetal; Fetal growth restriction; Infection; Neonatal; Perinatal; Pregnancy; SARS-CoV-2; Stillbirth.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Frequency histogram for all recruited participants from UK and non-UK centres.
See this image and copyright information in PMC

References

    1. Knight M, Ramakrishnan R, Bunch K, et al. Females in Hospital with SARS-CoV-2 infection, the association with pregnancy and pregnancy outcomes - report. :1-19.
    1. Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: National population based cohort study. BMJ. 2020;369(m2107). doi:10.1136/bmj.m2107. - PMC - PubMed
    1. Mullins E., Hudak M.L., Banerjee J., et al. Pregnancy and neonatal outcomes of COVID -19: co-reporting of common outcomes from PAN-COVID and AAP SONPM registries. Ultrasound Obstet Gynecol Published online. 2021 doi: 10.1002/uog.23619. - DOI - PMC - PubMed
    1. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370. doi:10.1136/bmj.m3320. - PMC - PubMed
    1. Banerjee J., Mullins E., Townson J., Playle R., Shaw C., Kirby N., et al. Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention. BMJ Open. 2021;11(1):e041247. - PMC - PubMed